Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide-mediated immunosuppression

C C Magee1, M H Sayegh

  • 1Laboratory of Immunogenetics and Transplantation, Brigham and Women's Hospital, Boston, MA, USA.

Current Opinion in Immunology
|November 22, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Donor antioxidant strategy prolongs cardiac allograft survival by attenuating tissue dendritic cell immunogenicity(†).

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Paradoxical functions of B7: CD28 costimulation in a MHC class II-mismatched cardiac transplant model.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Regulatory T cells in transplantation: what we know and what we do not know.

Transplantation proceedings·2009
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Novel peptides targeting T-cell receptor (TCR) interactions with MHC molecules show promise for modifying immune responses in transplantation. Research is exploring their mechanisms and potential clinical applications in human trials.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Molecular Medicine

Background:

  • Allorecognition, the process by which the immune system distinguishes self from non-self, is central to transplant rejection.
  • The T-cell receptor (TCR) interaction with the Major Histocompatibility Complex (MHC) molecule-peptide complex on antigen-presenting cells is a key step in the alloimmune response.
  • Developing strategies to modulate this response is crucial for improving transplant outcomes.

Purpose of the Study:

  • To explore novel biological strategies for modifying the alloimmune response.
  • To investigate the immunomodulatory potential of peptides derived from MHC molecules and structure-based peptides.
  • To understand the binding sites and mechanisms of action of these immunomodulatory peptides.

Main Methods:

Related Experiment Videos

  • Investigating peptides derived from MHC class I and II molecules.
  • Utilizing structure-based peptide design.
  • Evaluating immunomodulatory effects both in vitro and in vivo.
  • Conducting active research into peptide binding sites and mechanisms.

Main Results:

  • MHC-derived and structure-based peptides have demonstrated immunomodulatory effects.
  • These effects have been observed in both in vitro and in vivo experimental settings.
  • Ongoing investigations aim to elucidate the precise mechanisms and binding interactions.

Conclusions:

  • Peptides targeting TCR-MHC interactions represent a promising novel strategy for modulating alloimmune responses.
  • Further research into their mechanisms is warranted.
  • Early-stage clinical trials in human transplant recipients using an MHC class I peptide have commenced, indicating potential therapeutic value.